Clinical Trial Update: Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating rosuvastatin for long-term management in hypercholesterolaemic subjects with coronary heart disease; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hypercholesterolemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesteremia | Phase 4 | Status: COMPLETED | Results posted: 2011-07-15